{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:10:12Z","timestamp":1789722612522,"version":"4.0.1"},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1001\/jamadermatol.2020.2118","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T18:09:17Z","timestamp":1599070157000},"page":"1057","source":"Crossref","is-referenced-by-count":14,"title":["Association of the Psoriatic Microenvironment With Treatment Response"],"prefix":"10.1001","volume":"156","author":[{"given":"Gaofeng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Plastic and Aesthetic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China"},{"name":"Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Plastic and Aesthetic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noori","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Sweren","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sewon","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Plastic and Aesthetic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Garza","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"doi200039r1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence.","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"9","key":"doi200039r2","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1172\/JCI8633","article-title":"Skin innate immune system in psoriasis: friend or foe?","volume":"104","author":"Nickoloff","year":"1999","journal-title":"J Clin Invest"},{"key":"doi200039r3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3389\/fimmu.2018.01323","article-title":"The interleukin-23\/interleukin-17 axis links adaptive and innate immunity in psoriasis.","volume":"9","author":"Sch\u00f6n","year":"2018","journal-title":"Front Immunol"},{"issue":"7","key":"doi200039r4","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.4049\/jimmunol.1103414","article-title":"T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses.","volume":"188","author":"Tillack","year":"2012","journal-title":"J Immunol"},{"issue":"5","key":"doi200039r5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/bjd.1991.125.issue-5","article-title":"Psoriasis induced by interferon-alpha.","volume":"125","author":"Funk","year":"1991","journal-title":"Br J Dermatol"},{"issue":"7551","key":"doi200039r6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature14175","article-title":"Clinical improvement in psoriasis with specific targeting of interleukin-23.","volume":"521","author":"Kopp","year":"2015","journal-title":"Nature"},{"issue":"9993","key":"doi200039r7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(15)60125-8","article-title":"Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.","volume":"386","author":"Griffiths","year":"2015","journal-title":"Lancet"},{"issue":"52","key":"doi200039r8","doi-asserted-by":"publisher","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a).","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"doi200039r9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes.","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"6","key":"doi200039r10","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1073\/pnas.0409569102","article-title":"Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris.","volume":"102","author":"Chamian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"doi200039r11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3389\/fimmu.2018.00300","article-title":"Human langerhans cells with pro-inflammatory features relocate within psoriasis lesions.","volume":"9","author":"Eidsmo","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"doi200039r12","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"doi200039r13","doi-asserted-by":"publisher","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis.","volume":"5","author":"Lande","year":"2014","journal-title":"Nat Commun"},{"issue":"3","key":"doi200039r14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"\u00df-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis.","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"doi200039r15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/exd.2015.24.issue-7","article-title":"Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis.","volume":"24","author":"Reich","year":"2015","journal-title":"Exp Dermatol"},{"issue":"1","key":"doi200039r16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1172\/JCI117308","article-title":"Characterization of dermal dendritic cells in psoriasis. autostimulation of T lymphocytes and induction of Th1 type cytokines.","volume":"94","author":"Nestle","year":"1994","journal-title":"J Clin Invest"},{"issue":"7162","key":"doi200039r17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide.","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"issue":"1","key":"doi200039r18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaci.2015.10.046","article-title":"Targeting CD8(+) T cells prevents psoriasis development.","volume":"138","author":"Di Meglio","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"doi200039r19","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1172\/JCI27180","article-title":"Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation.","volume":"116","author":"Wang","year":"2006","journal-title":"J Clin Invest"},{"issue":"5","key":"doi200039r20","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jaci.2009.08.046","article-title":"Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.","volume":"124","author":"Zaba","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"doi200039r21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1186\/s12864-016-3188-y","article-title":"Network analysis of psoriasis reveals biological pathways and roles for coding and long non-coding RNAs.","volume":"17","author":"Ahn","year":"2016","journal-title":"BMC Genomics"},{"issue":"8","key":"doi200039r22","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.4049\/jimmunol.1301737","article-title":"Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody.","volume":"192","author":"Russell","year":"2014","journal-title":"J Immunol"},{"issue":"2","key":"doi200039r23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/bjd.12347","article-title":"The mechanistic basis for psoriasis immunopathogenesis: translating genotype to phenotype. Report of a workshop, Venice, 2012.","volume":"169","author":"Bachelez","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi200039r24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jid.2016.09.015","article-title":"Shrinking the Psoriasis Assessment Gap: Early Gene-Expression Profiling Accurately Predicts Response to Long-Term Treatment.","volume":"137","author":"Correa da Rosa","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"7","key":"doi200039r25","first-page":"617","article-title":"Higher psoriasis skin clearance is associated with lower annual indirect costs in the United States: a post hoc analysis from the CLEAR Study.","volume":"24","author":"Feldman","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"doi200039r26","first-page":"s104","article-title":"National Psoriasis Foundation: a patient-centric approach to improve access to psoriatic disease treatment.","volume":"22","author":"McCormick Howard","year":"2016","journal-title":"Am J Manag Care"},{"issue":"8","key":"doi200039r27","first-page":"859","article-title":"Impact of a patient support program on patient adherence to adalimumab and direct medical costs in Crohn\u2019s disease, ulcerative colitis, rheumatoid arthritis, psoriasis, psoriatic arthritis, and ankylosing spondylitis.","volume":"23","author":"Rubin","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"issue":"9","key":"doi200039r28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1080\/13696998.2017.1345749","article-title":"Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.","volume":"20","author":"Al Sawah","year":"2017","journal-title":"J Med Econ"},{"issue":"4","key":"doi200039r29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jaad.2014.11.028","article-title":"Estimated cost efficacy of systemic treatments that are approved by the US Food and Drug Administration for the treatment of moderate to severe psoriasis.","volume":"72","author":"D\u2019Souza","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi200039r30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles.","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"issue":"1","key":"doi200039r31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12920-019-0567-7","article-title":"Characterization of disease-specific cellular abundance profiles of chronic inflammatory skin conditions from deconvolution of biopsy samples.","volume":"12","author":"F\u00e9lix Garza","year":"2019","journal-title":"BMC Med Genomics"},{"issue":"5","key":"doi200039r32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1158\/2326-6066.CIR-18-0436","article-title":"Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures.","volume":"7","author":"Zeng","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"doi200039r33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.","volume":"41","author":"Nair","year":"2009","journal-title":"Nat Genet"},{"issue":"7","key":"doi200039r34","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1038\/jid.2014.28","article-title":"Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms.","volume":"134","author":"Li","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"11","key":"doi200039r35","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/jid.2012.184","article-title":"Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis.","volume":"132","author":"Su\u00e1rez-Fari\u00f1as","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"3","key":"doi200039r36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy\u2014analysis of Affymetrix GeneChip data at the probe level.","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"issue":"2","key":"doi200039r37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.5812\/ijem","article-title":"Normality tests for statistical analysis: a guide for non-statisticians.","volume":"10","author":"Ghasemi","year":"2012","journal-title":"Int J Endocrinol Metab"},{"issue":"3","key":"doi200039r38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4103\/0019-5154.182416","article-title":"Biostatistics series module 3: comparing groups: numerical variables.","volume":"61","author":"Hazra","year":"2016","journal-title":"Indian J Dermatol"},{"issue":"1","key":"doi200039r39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"Journal R Stat Soc"},{"issue":"10","key":"doi200039r40","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1172\/JCI127046","article-title":"Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome.","volume":"129","author":"Fakih","year":"2019","journal-title":"J Clin Invest"},{"issue":"2","key":"doi200039r41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1158\/1078-0432.CCR-19-0285","article-title":"Clonality, antigen recognition, and suppression of CD8+ T cells differentially affect prognosis of breast cancer subtypes.","volume":"26","author":"Hammerl","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"13","key":"doi200039r42","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1016\/j.celrep.2019.08.057","article-title":"GEF-H1 signaling upon microtubule destabilization is required for dendritic cell activation and specific anti-tumor responses.","volume":"28","author":"Kashyap","year":"2019","journal-title":"Cell Rep"},{"key":"doi200039r43","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47163","article-title":"Defined neuronal populations drive fatal phenotype in a mouse model of Leigh syndrome.","volume":"8","author":"Bolea","year":"2019","journal-title":"Elife"},{"issue":"12","key":"doi200039r44","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/s41588-019-0531-7","article-title":"Stalled developmental programs at the root of pediatric brain tumors.","volume":"51","author":"Jessa","year":"2019","journal-title":"Nat Genet"},{"issue":"501","key":"doi200039r45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7816","article-title":"Sensitization to immune checkpoint blockade through activation of a STAT1\/NK axis in the tumor microenvironment.","volume":"11","author":"Zemek","year":"2019","journal-title":"Sci Transl Med"},{"issue":"7783","key":"doi200039r46","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level.","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"issue":"1","key":"doi200039r47","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1038\/s41467-019-13208-z","article-title":"A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome.","volume":"10","author":"Misselbeck","year":"2019","journal-title":"Nat Commun"},{"key":"doi200039r48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.clim.2015.10.004","article-title":"Natural killer cells from psoriasis vulgaris patients have reduced levels of cytotoxicity associated degranulation and cytokine production.","volume":"177","author":"Dunphy","year":"2017","journal-title":"Clin Immunol"},{"issue":"6","key":"doi200039r49","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.4049\/jimmunol.1600446","article-title":"IL-35 decelerates the inflammatory process by regulating inflammatory cytokine secretion and M1\/M2 macrophage ratio in psoriasis.","volume":"197","author":"Zhang","year":"2016","journal-title":"J Immunol"},{"issue":"9","key":"doi200039r50","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1111\/jdv.2015.29.issue-9","article-title":"Increased circulating follicular helper T cells and activated B cells correlate with disease severity in patients with psoriasis.","volume":"29","author":"Niu","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"doi200039r51","doi-asserted-by":"publisher","first-page":"13581","DOI":"10.1038\/ncomms13581","article-title":"Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation.","volume":"7","author":"Singh","year":"2016","journal-title":"Nat Commun"},{"issue":"10","key":"doi200039r52","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.jid.2018.12.035","article-title":"Dysregulation of Akt-FOXO1 pathway leads to dysfunction of regulatory T cells in psoriasis patients.","volume":"139","author":"Li","year":"2019","journal-title":"J Invest Dermatol"},{"key":"doi200039r53","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3389\/fimmu.2019.00746","article-title":"Neutrophil extracellular traps promote inflammatory responses in psoriasis via activating epidermal TLR4\/IL-36R crosstalk.","volume":"10","author":"Shao","year":"2019","journal-title":"Front Immunol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2770071\/jamadermatology_wang_2020_oi_200039_1602515664.18497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T02:41:46Z","timestamp":1723516906000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2770071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.2118","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}